2018
DOI: 10.1007/s11739-018-1874-2
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines for the management of osteoporosis and fragility fractures

Abstract: The purpose of this document, a result of the harmonisation and revision of Guidelines published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide practical indications based on specific levels of evidence and various grades of recommendations, drawn from available literature, for the management of osteoporosis and for the diagnosis, prevention, and treatment of fragility fractures. These indications were discussed and formally approved by the delegates of the Italian Scientific Assoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
217
0
5

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 213 publications
(225 citation statements)
references
References 95 publications
1
217
0
5
Order By: Relevance
“…In postmenopausal women, the anti-fracture efficacy of denosumab has been documented for vertebral fractures, hip fractures and non-vertebral fractures (−68%, −40% and −20%, respectively, over three years of therapy). Moreover, evidence has shown that denosumab also has efficacy in the treatment of patients with breast cancer treated with aromatase inhibitors and men on androgen deprivation therapy for prostate cancer [129].…”
Section: Clinical Management Of Bone Health and Vitamin D Supplementamentioning
confidence: 99%
See 1 more Smart Citation
“…In postmenopausal women, the anti-fracture efficacy of denosumab has been documented for vertebral fractures, hip fractures and non-vertebral fractures (−68%, −40% and −20%, respectively, over three years of therapy). Moreover, evidence has shown that denosumab also has efficacy in the treatment of patients with breast cancer treated with aromatase inhibitors and men on androgen deprivation therapy for prostate cancer [129].…”
Section: Clinical Management Of Bone Health and Vitamin D Supplementamentioning
confidence: 99%
“…Follow-up of patients should ideally be conducted in the same facility with the same machine. DXA should be repeated every 1 to 2 years until findings are stable [129]. Due to the complexity in the management of osteopenia/osteoporosis in patients with malignant neoplasms, bone assessment and clinical management in GEP-NET patients need a multidisciplinary approach.…”
Section: Clinical Management Of Bone Health and Vitamin D Supplementamentioning
confidence: 99%
“…Osteoporosis is generally divided into two forms, primary osteoporosis and secondary osteoporosis. The primary osteoporosis mainly contains three categories, juvenile, postmenopausal, and senile the senile osteoporosis has become one significant health concern of the world as it is an age-related disorder that occurs in people's 70s, leading to the attenuation of both the cortical and trabecular bones [6].…”
Section: Introductionmentioning
confidence: 99%
“…Peripheral measurements of the forearm are reserved for special circumstances, particularly for patients in whom lumbar or femoral evaluation is not possible or not accurate, and those who are severely obese or suffer from primary hyperparathyroidism. 27 This is an epidemiological study that enrolled large groups of people, including obese subjects. Due to financial, place, and time constraints, we are unlikely to measure BMD at all sites.…”
Section: Discussionmentioning
confidence: 99%